In-vitro Diagnostics Market Size & Share, by Product Type (Instruments, Reagents & Consumables); Test (Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Hematology); Application (Infectious Diseases, Cardiology, Oncology, Gastroenterology) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

  • Report ID: 1354
  • Published Date: Feb 06, 2023
  • Report Format: PDF, PPT

Companies Dominating the In-Vitro Diagnostics Landscape

top-features-companies
    • Abbott Laboratories
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Roche Diagnostics
    • DiaSorin S. p. A.
    • Johnson & Johnson corporation
    • Becton, Dickinson and Company
    • Siemens Healthineers
    • Danaher Corporations
    • Bio-Rad Laboratories
    • Thermo Fisher Scientific 
    • Pfizer Inc.

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Abbott Laboratories received US FDA clearance for the Freestyle libre 2 iOS application for use with compatible iPhones.

  • Roche Diagnostics launched the Cobas pulse system, a blood glucose management solution with mobile digital health capabilities to improve patient care.


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 1354
  • Published Date: Feb 06, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing awareness towards point-of-care testing from centralized testing, and increase in chronic and infectious diseases are anticipated to be the major factors driving the growth of the in-vitro diagnostics market.

The market is anticipated to attain a CAGR of ~5% over the forecast period, i.e., 2023-2033.

High cost of diagnostic services and machinery maintenance and unfavorable scenario are the challenges affecting the market growth.

The market in North America is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Abbott, Roche Diagnostics, DiaSorin, Johnson & Johnson, Becton, Dickinson and Company, Siemens Healthineers, Danaher Corporations, Bio-Rad Laboratories, and Thermo Fisher Scientific.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product type, test type, application, end-user, and by region.

The oncology is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying